Skip to main content
JOONGANG ADVANCED MATERIALS Co., Ltd logo

JOONGANG ADVANCED MATERIALS Co., Ltd — Investor Relations & Filings

Ticker · 051980 ISIN · KR7051980001 KO Manufacturing
Open in API
Filings indexed 639 across all filing types
Latest filing 2020-09-29 Capital/Financing Update
Country KR South Korea
Listing KO 051980

About JOONGANG ADVANCED MATERIALS Co., Ltd

http://www.jamaterials.com

JOONGANG ADVANCED MATERIALS Co., Ltd. is a manufacturer engaged in two primary business segments: communications equipment and building materials. The company develops, produces, and markets wired communication equipment and optical components for the telecommunications sector. In its building materials division, it manufactures and distributes a range of PVC products, including windows and doors, as well as ventilation systems. The company's portfolio also includes plastic products, LED lighting, and medical devices.

Recent filings

Filing Released Lang Actions
[기재정정]기타경영사항(자율공시)(제7회 무기명식 이권부 무보증 사모 전환사채 취득 후 재매각)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from a Korean company (Central Bio) regarding the amendment of a previous disclosure (dated 2020-09-11) concerning the resale of convertible bonds. It details the specific changes to the payment schedule for the transaction. Since this is a formal regulatory disclosure regarding capital structure and financing activities (specifically the resale of convertible bonds), it falls under the 'Capital/Financing Update' category.
2020-09-29 Korean
증권발행결과(자율공시)(제8회차 CB)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from a Korean company (Central Bio) regarding the 'Result of Securities Issuance' (증권 발행결과), specifically for a convertible bond (CB). This falls under the category of company financing and capital structure changes. According to the provided definitions, 'CAP' (Capital/Financing Update) is the most accurate classification for updates on fundraising and financing activities.
2020-09-29 Korean
[기재정정]기타경영사항(자율공시)(제7회 무기명식 이권부 무보증 사모 전환사채 취득 후 재매각)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system, specifically a 'Correction Report' (정정신고) regarding a previous disclosure about the resale of convertible bonds (CB). It details the correction of a specific financial figure (the remaining balance of a transaction) related to the company's capital structure and financing activities. Since it is a formal regulatory disclosure of a corporate event (financing/capital-related) and does not fit into specific categories like 'Annual Report' or 'Earnings Release', it is classified as a Regulatory Filing (RNS).
2020-09-29 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Extraordinary General Meeting of Shareholders' (주주총회소집공고) for Central Bio. It contains the meeting agenda, details on director candidates (including their backgrounds and qualifications), and information regarding corporate governance and management activities. This document is a standard proxy statement used to inform shareholders of upcoming votes and provide necessary background information for those votes, which fits the definition of a Proxy Solicitation & Information Statement.
2020-09-29 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Solicitation of Proxy' (위임권유) filed by Central Bio Co., Ltd. with the Financial Services Commission and the Korea Exchange. It contains details regarding the solicitation of voting rights for an upcoming Extraordinary General Meeting (EGM), including the purpose of the meeting, information about the solicitors, and details on director candidates. This aligns perfectly with the definition of a Proxy Solicitation & Information Statement (PSI).
2020-09-29 Korean
합병등종료보고서(자산양수도)
M&A Activity Classification · 100% confidence The document is a 'Report on the Completion of Merger, etc.' (합병등종료보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details the finalization of a corporate asset transfer (sale of shares in Barun Technology) by Central Bio. Since this document reports on the completion of a specific M&A-related transaction (asset transfer/divestiture), it falls under the M&A Activity category.
2020-09-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.